Clinical Trial

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 6, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.
Trial Details
NCT Number NCT06070272
Lead Sponsor Power Life Sciences Inc.
Conditions Recurrent Prostate Cancer
Enrollment 500 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-10-06